{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:55:10Z","timestamp":1790898910941,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Science and Technology Bureau Municipal School (Institute) Co-funded Project","award":["202201020443"],"award-info":[{"award-number":["202201020443"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04275-y","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:51:36Z","timestamp":1755651096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China"],"prefix":"10.1186","volume":"25","author":[{"given":"Weihong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"8","key":"4275_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080667","volume":"7","author":"Y Hassan","year":"2021","unstructured":"Hassan Y, Chew SY, Than LTL. Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival. J Fungi. 2021;7(8): 667. https:\/\/doi.org\/10.3390\/jof7080667.","journal-title":"J Fungi"},{"issue":"6","key":"4275_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/tid.12696","volume":"18","author":"DR Andes","year":"2016","unstructured":"Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the united states: results of the Transplant-Associated infection surveillance network (TRANSNET). Transpl Infect Dis. 2016;18(6):921\u201331. https:\/\/doi.org\/10.1111\/tid.12696.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"4275_CR3","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1038\/s41598-020-63326-x","volume":"10","author":"ZF Al-Baqsami","year":"2020","unstructured":"Al-Baqsami ZF, Ahmad S, Khan Z. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait. Sci Rep. 2020;10(1):6238. https:\/\/doi.org\/10.1038\/s41598-020-63326-x.","journal-title":"Sci Rep"},{"key":"4275_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02038","volume":"7","author":"S Delli\u00e8re","year":"2016","unstructured":"Delli\u00e8re S, Healey K, Gits-Muselli M, Carrara B, Barbaro A, Guigue N, Lecefel C, Touratier S, Desnos-Ollivier M, Perlin DS, Bretagne S, Alanio A. Fluconazole and echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a French cohort of patients harboring low rates of resistance. Front Microbiol. 2016;7: 2038. https:\/\/doi.org\/10.3389\/fmicb.2016.02038.","journal-title":"Front Microbiol"},{"issue":"5","key":"4275_CR5","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in Cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280\u201393. https:\/\/doi.org\/10.1016\/S1473-3099(24)00749-7.","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"4275_CR6","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/cells122226555","volume":"12","author":"KM Czajka","year":"2023","unstructured":"Czajka KM, Venkataraman K, Brabant-Kirwan D, Santi SA, Verschoor C, Appanna VD, et al. Molecular mechanisms associated with antifungal resistance in pathogenic Candida species. Cells. 2023;12(22):2655. https:\/\/doi.org\/10.3390\/cells122226555.","journal-title":"Cells"},{"issue":"12","key":"4275_CR7","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1128\/AAC.04726-15","volume":"59","author":"RK Shields","year":"2015","unstructured":"Shields RK, Nguyen MH, Press EG, Cumbie R, Driscoll E, Pasculle AW, et al. Rate of FKS mutations among consecutive Candida isolates causing bloodstream infection. Antimicrob Agents Chemother. 2015;59(12):7465\u201370. https:\/\/doi.org\/10.1128\/AAC.04726-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4275_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s15010-019-01374-4","volume":"48","author":"AT Coste","year":"2020","unstructured":"Coste AT, Kritikos A, Li J, Khanna N, Goldenberger D, Garzoni C, et al. Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland. Infection. 2020;48(5):761\u20136. https:\/\/doi.org\/10.1007\/s15010-019-01374-4.","journal-title":"Infection"},{"issue":"8","key":"4275_CR9","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1128\/AAC.02428-14","volume":"58","author":"CD Pham","year":"2014","unstructured":"Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, et al. Role of FKS mutations in Candida glabrata: MIC values, Echinocandin resistance, and multidrug resistance. Antimicrob Agents Chemother. 2014;58(8):4690\u20136. https:\/\/doi.org\/10.1128\/AAC.02428-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"4275_CR10","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.1128\/AAC.01247-16","volume":"60","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Nagasaki Y, Kordalewska M, Press EG, Shields RK, Nguyen MH, et al. Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata. Antimicrob Agents Chemother. 2016;60(11):6573\u20137. https:\/\/doi.org\/10.1128\/AAC.01247-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"4275_CR11","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/cid\/ciu407","volume":"59","author":"ND Beyda","year":"2014","unstructured":"Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014;59(6):819\u201325. https:\/\/doi.org\/10.1093\/cid\/ciu407.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"4275_CR12","doi-asserted-by":"publisher","first-page":"e02503","DOI":"10.1128\/AAC.02503-18","volume":"63","author":"A Arastehfar","year":"2019","unstructured":"Arastehfar A, Daneshnia F, Zomorodian K, Najafzadeh MJ, Khodavaisy S, Zarrinfar H, et al. Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1. Antimicrob Agents Chemother. 2019;63(7):e02503\u201318. https:\/\/doi.org\/10.1128\/AAC.02503-18.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"4275_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/myc.12472","volume":"59","author":"U Klotz","year":"2016","unstructured":"Klotz U, Schmidt D, Willinger B, Steinmann E, Buer J, Rath MF, Steinmann J. Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria. Mycoses. 2016;59(5):312\u20138. https:\/\/doi.org\/10.1111\/myc.12472.","journal-title":"Mycoses"},{"key":"4275_CR14","unstructured":"Clinical and Laboratory Standards Institute. (2022). Performance Standards for Antifungal Susceptibility Testing of Yeasts (3rd ed., CLSI supplement M27M44S). Clinical and Laboratory Standards Institute."},{"issue":"12","key":"4275_CR15","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1128\/JCM.41.12.5709-5717.2003","volume":"41","author":"AR Dodgson","year":"2003","unstructured":"Dodgson AR, Pujol C, Denning DW, Soll DR, Fox AJ. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J Clin Microbiol. 2003;41(12):5709\u201317. https:\/\/doi.org\/10.1128\/JCM.41.12.5709-5717.2003.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"4275_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jof10050326","volume":"10","author":"JC Hern\u00e1ndez-Pab\u00f3n","year":"2024","unstructured":"Hern\u00e1ndez-Pab\u00f3n JC, Tabares B, Gil \u00d3, Lugo-S\u00e1nchez C, Santana A, Bar\u00f3n A, Firacative C. Candida non-albicans and non-auris causing invasive candidiasis in a fourth-level hospital in Colombia: epidemiology, antifungal susceptibility, and genetic diversity. J Fungi. 2024;10(5): 326. https:\/\/doi.org\/10.3390\/jof10050326.","journal-title":"J Fungi"},{"issue":"Suppl 6","key":"4275_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","volume":"20","author":"J Guinea","year":"2014","unstructured":"Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(Suppl 6):5\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"4275_CR18","doi-asserted-by":"publisher","first-page":"e00577","DOI":"10.1128\/JCM.00577-18","volume":"56","author":"M Xiao","year":"2018","unstructured":"Xiao M, Sun ZY, Kang M, Guo DW, Liao K, Chen SC, China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group, et al. Five-Year National surveillance of invasive candidiasis: species distribution and Azole susceptibility from the China hospital invasive fungal surveillance net (CHIF-NET) study. J Clin Microbiol. 2018;56(7):e00577\u201318. https:\/\/doi.org\/10.1128\/JCM.00577-18.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"4275_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","volume":"44","author":"J Onishi","year":"2000","unstructured":"Onishi J, Meinz M, Thompson J, Curotto J, Dreikorn S, Rosenbach M, et al. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother. 2000;44(2):368\u201377. https:\/\/doi.org\/10.1128\/AAC.44.2.368-377.2000.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"4275_CR20","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383\u201392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"4275_CR21","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3201\/eid2011.140685","volume":"20","author":"D Farmakiotis","year":"2014","unstructured":"Farmakiotis D, Tarrand JJ, Kontoyiannis DP. Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis. 2014;20(11):1833\u201340. https:\/\/doi.org\/10.3201\/eid2011.140685.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"4275_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jof4030105","volume":"4","author":"KR Healey","year":"2018","unstructured":"Healey KR, Perlin DS. Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata. J Fungi. 2018;4(3): 105. https:\/\/doi.org\/10.3390\/jof4030105.","journal-title":"J Fungi"},{"issue":"9","key":"4275_CR23","doi-asserted-by":"publisher","first-page":"e00783","DOI":"10.1128\/AAC.00783-20","volume":"64","author":"HO Khalifa","year":"2020","unstructured":"Khalifa HO, Arai T, Majima H, Watanabe A, Kamei K. Genetic basis of azole and echinocandin resistance in clinical Candida glabrata in Japan. Antimicrob Agents Chemother. 2020;64(9):e00783-20. https:\/\/doi.org\/10.1128\/AAC.00783-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"4275_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00880","volume":"8","author":"X Hou","year":"2017","unstructured":"Hou X, Xiao M, Chen SC, Kong F, Wang H, Chu YZ, et al. Molecular epidemiology and antifungal susceptibility of Candida glabrata in China (August 2009 to July 2014): a multi-center study. Front Microbiol. 2017;8: 880. https:\/\/doi.org\/10.3389\/fmicb.2017.00880.","journal-title":"Front Microbiol"},{"issue":"1","key":"4275_CR25","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1080\/21505594.2022.2123325","volume":"13","author":"H Bilal","year":"2022","unstructured":"Bilal H, Shafiq M, Hou B, Islam R, Khan MN, Khan RU, Zeng Y. Distribution and antifungal susceptibility pattern of Candida species from mainland china: a systematic analysis. Virulence. 2022;13(1):1573\u201389. https:\/\/doi.org\/10.1080\/21505594.2022.2123325.","journal-title":"Virulence"},{"issue":"6","key":"4275_CR26","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/jac\/dkac075","volume":"77","author":"PC Georgiou","year":"2022","unstructured":"Georgiou PC, Arendrup MC, Meletiadis J. Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates. J Antimicrob Chemother. 2022;77(6):1655\u201361. https:\/\/doi.org\/10.1093\/jac\/dkac075.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"4275_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijantimicag","volume":"50","author":"D Farmakiotis","year":"2017","unstructured":"Farmakiotis D, Kontoyiannis DP. Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management. International Journal of Antimicrobial Agents. 2017;50(3):318\u201324. https:\/\/doi.org\/10.1016\/j.ijantimicag.","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"5","key":"4275_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ijantimicag.2017.05.012","volume":"50","author":"F Morio","year":"2017","unstructured":"Morio F, Jensen RH, Le Pape P, Arendrup MC. Molecular basis of antifungal drug resistance in yeasts. Int J Antimicrob Agents. 2017;50(5):599\u2013606. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.05.012.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"4275_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2217\/fmb.11.19","volume":"6","author":"DS Perlin","year":"2011","unstructured":"Perlin DS. Current perspectives on Echinocandin class drugs. Future Microbiol. 2011;6(4):441\u201357. https:\/\/doi.org\/10.2217\/fmb.11.19.","journal-title":"Future Microbiol"},{"issue":"Suppl 1","key":"4275_CR30","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","volume":"6","author":"MA Pfaller","year":"2019","unstructured":"Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997\u20132016. Open Forum Infect Dis. 2019;6(Suppl 1):S79\u201394. https:\/\/doi.org\/10.1093\/ofid\/ofy358.","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"4275_CR31","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1128\/JCM.03106-15","volume":"54","author":"S Katiyar","year":"2016","unstructured":"Katiyar S, Shiffrin E, Shelton C, Healey K, Vermitsky JP, Edlind T. Evaluation of polymorphic locus sequence typing for Candida glabrata epidemiology. J Clin Microbiol. 2016;54(4):1042\u201350. https:\/\/doi.org\/10.1128\/JCM.03106-15.","journal-title":"J Clin Microbiol"},{"key":"4275_CR32","doi-asserted-by":"publisher","first-page":"1455145","DOI":"10.3389\/fcimb.2024.1455145","volume":"14","author":"SJ Huang","year":"2024","unstructured":"Huang SJ, Lv G, Song YH, Zhao JT, Liu JY, Wang LL, Xiang MJ. Antifungal susceptibility, molecular epidemiology, and clinical risk factors of Candida glabrata in intensive care unit in a Chinese tertiary hospital. Front Cell Infect Microbiol. 2024;14:1455145. https:\/\/doi.org\/10.3389\/fcimb.2024.1455145.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"4275_CR33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1586\/14787210.2013.841543","volume":"11","author":"K Vanstraelen","year":"2013","unstructured":"Vanstraelen K, Lagrou K, Maertens J, Wauters J, Willems L, Spriet I. The Eagle-like effect of echinocandins: what\u2019s in a name? Expert Rev Anti-Infect Ther. 2013;11(11):1179\u201391. https:\/\/doi.org\/10.1586\/14787210.2013.841543.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"4275_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1128\/JCM.02481-13","volume":"52","author":"MA Pfaller","year":"2014","unstructured":"Pfaller MA, Messer SA, Diekema DJ, Jones RN, Castanheira M. Use of micafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 3,764 clinical isolates of Candida by use of CLSI methods and interpretive criteria. J Clin Microbiol. 2014;52(1):108\u201314. https:\/\/doi.org\/10.1128\/JCM.02481-13.","journal-title":"J Clin Microbiol"},{"key":"4275_CR35","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. (2022). Overview of antifungal ecoffs and clinical breakpoints for yeasts, moulds and dermatophytes using the EUCAST e.def 7.3, e.def 9.4 and e.def 11.0 procedures. Version 3."},{"issue":"9","key":"4275_CR36","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1128\/AAC","volume":"56","author":"RK Shields","year":"2012","unstructured":"Shields RK, Nguyen MH, Press EG, Kwa AL, Cheng S, Du C, Clancy CJ. The presence of an FKS mutation rather than MIC is an independent risk factor for failure of Echinocandin therapy among patients with invasive candidiasis due to Candida glabrata. Antimicrob Agents Chemother. 2012;56(9):4862\u20139. https:\/\/doi.org\/10.1128\/AAC. 00027\u2013\u200912.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4275_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3138\/jammi-2020-0023","volume":"6","author":"Y Shabi","year":"2021","unstructured":"Shabi Y, Russell-Tattrie A, Bharat A, Haldane D, Patriquin G. A pseudo-outbreak of Echinocandin-resistant Candida glabrata: the unreliability of Caspofungin testing in predicting Echinocandin susceptibility. J Assoc Med Microbiol Infect Dis Can. 2021;6(1):1\u20132. https:\/\/doi.org\/10.3138\/jammi-2020-0023.","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"issue":"12","key":"4275_CR38","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.1128\/AAC.01519-13","volume":"57","author":"A Espinel-Ingroff","year":"2013","unstructured":"Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, et al. Interlaboratory variability of Caspofungin mics for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother. 2013;57(12):5836\u201342. https:\/\/doi.org\/10.1128\/AAC.01519-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"4275_CR39","unstructured":"Clinical and Laboratory Standards Institute (CLSI). (2020). Performance standards for antifungal susceptibility testing of yeasts (2nd ed., CLSI supplement M60). Wayne, PA: CLSI."},{"key":"4275_CR40","doi-asserted-by":"publisher","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). (2020). Breakpoint tables for interpretation of MICs for antifungal agents, version 10.0. Basel, CH: EUCAST. Retrieved from https:\/\/doi.org\/10.2807\/wd0060-2020","DOI":"10.2807\/wd0060-2020"},{"issue":"6","key":"4275_CR41","doi-asserted-by":"publisher","first-page":"e00153","DOI":"10.1128\/AAC.00153-18","volume":"62","author":"X Hou","year":"2018","unstructured":"Hou X, Xiao M, Wang H, Yu SY, Zhang G, Zhao Y, et al. Profiling of PDR1 and MSH2 in Candida glabrata bloodstream isolates from a multicenter study in China. Antimicrob Agents Chemother. 2018;62(6):e00153\u201318. https:\/\/doi.org\/10.1128\/AAC.00153-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"4275_CR42","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3389\/fmicb.2018.01523","volume":"9","author":"SA Byun","year":"2018","unstructured":"Byun SA, Won EJ, Kim MN, Lee WG, Lee K, Lee HS, et al. Multilocus sequence typing (MLST) genotypes of Candida glabrata bloodstream isolates in Korea: association with antifungal resistance, mutations in mismatch repair gene (Msh2), and clinical outcomes. Front Microbiol. 2018;9:1523. https:\/\/doi.org\/10.3389\/fmicb.2018.01523.","journal-title":"Front Microbiol"},{"key":"4275_CR43","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3389\/fmicb.2019.01678","volume":"10","author":"N Kiasat","year":"2019","unstructured":"Kiasat N, Rezaei-Matehkolaei A, Mahmoudabadi AZ. Microsatellite typing and antifungal susceptibility of Candida glabrata strains isolated from patients with Candida vaginitis. Front Microbiol. 2019;10:1678. https:\/\/doi.org\/10.3389\/fmicb.2019.01678.","journal-title":"Front Microbiol"},{"issue":"5","key":"4275_CR44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/mmy\/myv013","volume":"53","author":"C Dhieb","year":"2015","unstructured":"Dhieb C, Normand AC, Al-Yasiri M, Chaker E, Euch E, Vranckx D, K., et al. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata. Med Mycol. 2015;53(5):462\u20139. https:\/\/doi.org\/10.1093\/mmy\/myv013.","journal-title":"Med Mycol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04275-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04275-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04275-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:17:40Z","timestamp":1757438260000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04275-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4275"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04275-y","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki.\u00a0Approval was granted by the Ethics Committee of Guangzhou Medical University Affiliated First Hospital (Ethics Numbers:2021\u00a0K-40). Strains were collected as part of the routine clinical management of patients, according to the national guidelines in China. Therefore, informed consent was not sought, and an informed consent waiver was approved by the institutional ethical committee of Guangzhou Medical University Affiliated First Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"521"}}